ARCHIVES

Pill Associated With Cancer In BRCA1 Mutation Carriers

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

RPR Grant To NABCO Does Not Support Advocacy, Firm Says

November 10, 1995

NCCS Changes Web Domain; NCCN Plans Clinical Trials Network

June 7, 2002

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

Fisher Files Motion In Database Flagging Suit; Documents Examine Role Of Former NCI Director Broder

October 20, 1995

Technology Transfer Is Theme For 1990s, Broder Tells Writers; Laszio Offers Predictions On Treatment Advances

April 6, 1990